Getting priority claims right - an EPO/European perspective

07/02/20

Priority is one of those issues which can easily go wrong, particularly where there are multiple parties working together. However, when it does go wrong and a priority claim is found to be invalid, granted patents can often be revoked.

EPO Board of Appeal finds Broad Institute’s CRISPR patent to lack valid priority claim and upholds revocation of patent (T 0844/18)

17/01/20

This week’s hearing at the EPO concerning Broad Institute’s CRISPR/Cas9 patent was arguably one of the most high-profile appeals recently...